Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity	METTL3 PCIF1	6.46e-05	2	161	2	GO:0016422
GeneOntologyMolecularFunction	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides	CAD DPYSL4 CRMP1	2.67e-04	16	161	3	GO:0016812
GeneOntologyMolecularFunction	modification-dependent protein binding	RNF169 FMR1 ANK2 BRD3 PHF8 CXXC1 CDY1 MPHOSPH8	2.73e-04	206	161	8	GO:0140030
GeneOntologyMolecularFunction	histone binding	FMR1 BRD3 CHD7 PHF8 SRCAP CXXC1 SBNO2 CDY1 MPHOSPH8	3.08e-04	265	161	9	GO:0042393
GeneOntologyMolecularFunction	glutaminase activity	CAD GLS	3.84e-04	4	161	2	GO:0004359
GeneOntologyMolecularFunction	sequence-specific mRNA binding	FMR1 SSB NOVA1	4.53e-04	19	161	3	GO:1990825
GeneOntologyMolecularFunction	methylated histone binding	FMR1 PHF8 CXXC1 CDY1 MPHOSPH8	6.59e-04	86	161	5	GO:0035064
GeneOntologyMolecularFunction	methylation-dependent protein binding	FMR1 PHF8 CXXC1 CDY1 MPHOSPH8	7.32e-04	88	161	5	GO:0140034
Domain	-	COL6A3 MATN1 MATN2 ITGB4 PARP4 VWA5B1	4.12e-05	74	160	6	3.40.50.410
Domain	Metal_Hydrolase	AMPD2 CAD DPYSL4 CRMP1	4.82e-05	24	160	4	IPR032466
Domain	Chromo	CHD7 CDY1 MPHOSPH8 CDY2A	6.69e-05	26	160	4	PF00385
Domain	Amidohydro_1	CAD DPYSL4 CRMP1	7.08e-05	10	160	3	PF01979
Domain	Metal-dep_hydrolase_composite	CAD DPYSL4 CRMP1	7.08e-05	10	160	3	IPR011059
Domain	Cl_channel-K	CLCNKA CLCNKB	7.29e-05	2	160	2	IPR002250
Domain	VWFA	COL6A3 MATN1 MATN2 ITGB4 PARP4 VWA5B1	7.36e-05	82	160	6	PS50234
Domain	VWA	COL6A3 MATN1 MATN2 ITGB4 PARP4 VWA5B1	8.43e-05	84	160	6	SM00327
Domain	CHROMO_1	CHD7 CDY1 MPHOSPH8 CDY2A	9.05e-05	28	160	4	PS00598
Domain	CHROMO_2	CHD7 CDY1 MPHOSPH8 CDY2A	9.05e-05	28	160	4	PS50013
Domain	Amidohydro-rel	CAD DPYSL4 CRMP1	9.68e-05	11	160	3	IPR006680
Domain	Chromodomain-like	CHD7 CDY1 MPHOSPH8 CDY2A	1.55e-04	32	160	4	IPR016197
Domain	Chromo/shadow_dom	CHD7 CDY1 MPHOSPH8 CDY2A	1.75e-04	33	160	4	IPR000953
Domain	CHROMO	CHD7 CDY1 MPHOSPH8 CDY2A	1.75e-04	33	160	4	SM00298
Domain	VWF_A	COL6A3 MATN1 MATN2 ITGB4 PARP4 VWA5B1	2.09e-04	99	160	6	IPR002035
Domain	PARP_ALPHA_HD	PARP3 PARP4	4.33e-04	4	160	2	PS51060
Domain	Poly(ADP-ribose)pol_reg_dom	PARP3 PARP4	4.33e-04	4	160	2	IPR004102
Domain	Matrilin_ccoil	MATN1 MATN2	4.33e-04	4	160	2	SM01279
Domain	-	MATN1 MATN2	4.33e-04	4	160	2	1.20.5.30
Domain	-	PARP3 PARP4	4.33e-04	4	160	2	1.20.142.10
Domain	Matrilin_ccoil	MATN1 MATN2	4.33e-04	4	160	2	PF10393
Domain	Matrilin_coiled-coil_trimer	MATN1 MATN2	4.33e-04	4	160	2	IPR019466
Domain	FYrich_C	KMT2B KMT2D	7.17e-04	5	160	2	IPR003889
Domain	FYrich_N	KMT2B KMT2D	7.17e-04	5	160	2	IPR003888
Domain	FYRC	KMT2B KMT2D	7.17e-04	5	160	2	SM00542
Domain	FYRN	KMT2B KMT2D	7.17e-04	5	160	2	SM00541
Domain	K_chnl_volt-dep_KCNQ_C	KCNQ4 KCNQ2	7.17e-04	5	160	2	IPR013821
Domain	K_chnl_volt-dep_KCNQ	KCNQ4 KCNQ2	7.17e-04	5	160	2	IPR003937
Domain	FYRN	KMT2B KMT2D	7.17e-04	5	160	2	PF05964
Domain	FYRC	KMT2B KMT2D	7.17e-04	5	160	2	PF05965
Domain	FYRC	KMT2B KMT2D	7.17e-04	5	160	2	PS51543
Domain	FYRN	KMT2B KMT2D	7.17e-04	5	160	2	PS51542
Domain	KCNQ_channel	KCNQ4 KCNQ2	7.17e-04	5	160	2	PF03520
Domain	EGF	NID2 MATN1 MATN2 LRP6 TNXB NOTCH2	7.61e-04	126	160	6	PF00008
Domain	EGF	NID2 MATN1 MATN2 GPR179 CNTNAP5 LRP6 TNXB NOTCH2	9.66e-04	235	160	8	SM00181
Domain	DDHD	SEC23IP DDHD2	1.07e-03	6	160	2	PF02862
Domain	DDHD	SEC23IP DDHD2	1.07e-03	6	160	2	PS51043
Domain	DDHD_dom	SEC23IP DDHD2	1.07e-03	6	160	2	IPR004177
Domain	Hydantoinase/dihydroPyrase	DPYSL4 CRMP1	1.07e-03	6	160	2	IPR011778
Domain	DDHD	SEC23IP DDHD2	1.07e-03	6	160	2	SM01127
Domain	C2H2_Znf_fam	ZNF202 ZSCAN29 ZNF641	1.09e-03	24	160	3	IPR027775
Domain	VWA	COL6A3 MATN1 MATN2 PARP4	1.35e-03	56	160	4	PF00092
Domain	-	DPYSL4 CRMP1	1.97e-03	8	160	2	2.30.40.10
Domain	EGF_2	NID2 MATN1 MATN2 ITGB4 CNTNAP5 LRP6 TNXB NOTCH2	2.07e-03	265	160	8	PS01186
Domain	Cl-channel_core	CLCNKA CLCNKB	2.52e-03	9	160	2	IPR014743
Domain	-	CLCNKA CLCNKB	2.52e-03	9	160	2	1.10.3080.10
Domain	Voltage_CLC	CLCNKA CLCNKB	2.52e-03	9	160	2	PF00654
Domain	Cl-channel_volt-gated	CLCNKA CLCNKB	2.52e-03	9	160	2	IPR001807
Domain	VIT	PARP4 VWA5B1	3.14e-03	10	160	2	PS51468
Domain	VIT	PARP4 VWA5B1	3.14e-03	10	160	2	IPR013694
Domain	Chromo_dom_subgr	CDY1 CDY2A	3.14e-03	10	160	2	IPR017984
Domain	Ank	ANK2 PPP1R13B DZANK1 GLS MPHOSPH8 NOTCH2 AGAP2	3.55e-03	228	160	7	PF00023
Domain	ZF_CXXC	KMT2B CXXC1	3.81e-03	11	160	2	PS51058
Domain	Znf_CXXC	KMT2B CXXC1	3.81e-03	11	160	2	IPR002857
Domain	zf-CXXC	KMT2B CXXC1	3.81e-03	11	160	2	PF02008
Domain	PHD	KMT2B PHF8 CXXC1 KMT2D	3.93e-03	75	160	4	PF00628
Domain	KH_1	FMR1 QKI NOVA1	4.18e-03	38	160	3	PF00013
Domain	EGF_3	NID2 MATN1 MATN2 CNTNAP5 LRP6 TNXB NOTCH2	4.19e-03	235	160	7	PS50026
Domain	-	FMR1 QKI NOVA1	4.50e-03	39	160	3	3.30.1370.10
Domain	DUF4599	SPATA31C2 SPATA31C1	4.55e-03	12	160	2	PF15371
Domain	DUF4599	SPATA31C2 SPATA31C1	4.55e-03	12	160	2	IPR027970
Domain	Znf_PHD-finger	KMT2B PHF8 CXXC1 KMT2D	4.74e-03	79	160	4	IPR019787
Domain	KH	FMR1 QKI NOVA1	4.83e-03	40	160	3	SM00322
Domain	KH_dom	FMR1 QKI NOVA1	4.83e-03	40	160	3	IPR004087
Domain	FN3	COL6A3 ITGB4 KIAA0319 MYOM2 MDGA1 TNXB	5.25e-03	185	160	6	SM00060
Domain	KH_TYPE_1	FMR1 QKI NOVA1	5.55e-03	42	160	3	PS50084
Domain	-	ANK2 PPP1R13B DZANK1 GLS MPHOSPH8 NOTCH2 AGAP2	5.60e-03	248	160	7	1.25.40.20
Domain	EGF-like_dom	NID2 MATN1 MATN2 CNTNAP5 LRP6 TNXB NOTCH2	5.72e-03	249	160	7	IPR000742
Domain	ANK	ANK2 PPP1R13B DZANK1 GLS MPHOSPH8 NOTCH2 AGAP2	5.97e-03	251	160	7	SM00248
Domain	Dynein_heavy_chain_D4_dom	DNAH2 DNAH6	6.20e-03	14	160	2	IPR024317
Domain	Dynein_HC_stalk	DNAH2 DNAH6	6.20e-03	14	160	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH2 DNAH6	6.20e-03	14	160	2	IPR013602
Domain	DHC_N2	DNAH2 DNAH6	6.20e-03	14	160	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH2 DNAH6	6.20e-03	14	160	2	IPR011704
Domain	MT	DNAH2 DNAH6	6.20e-03	14	160	2	PF12777
Domain	AAA_8	DNAH2 DNAH6	6.20e-03	14	160	2	PF12780
Domain	Ldl_recept_b	NID2 LRP6	6.20e-03	14	160	2	PF00058
Domain	LDLRB	NID2 LRP6	6.20e-03	14	160	2	PS51120
Domain	AAA_5	DNAH2 DNAH6	6.20e-03	14	160	2	PF07728
Domain	ANK_REPEAT	ANK2 PPP1R13B DZANK1 GLS MPHOSPH8 NOTCH2 AGAP2	6.23e-03	253	160	7	PS50088
Domain	P-loop_NTPase	KIF21B MAGI1 ABCC1 ZGRF1 DNAH2 MAGI3 MCM7 CHD7 SRCAP NLRP3 SBNO2 EHD2 DNAH6 AQR AGAP2	6.28e-03	848	160	15	IPR027417
Domain	KH_dom_type_1	FMR1 QKI NOVA1	6.32e-03	44	160	3	IPR004088
Domain	Ankyrin_rpt-contain_dom	ANK2 PPP1R13B DZANK1 GLS MPHOSPH8 NOTCH2 AGAP2	6.36e-03	254	160	7	IPR020683
Domain	ANK_REP_REGION	ANK2 PPP1R13B DZANK1 GLS MPHOSPH8 NOTCH2 AGAP2	6.36e-03	254	160	7	PS50297
Domain	EGF_CA	NID2 MATN1 MATN2 NOTCH2	6.39e-03	86	160	4	PF07645
Domain	DHC_fam	DNAH2 DNAH6	7.12e-03	15	160	2	IPR026983
Domain	Dynein_heavy	DNAH2 DNAH6	7.12e-03	15	160	2	PF03028
Domain	LY	NID2 LRP6	7.12e-03	15	160	2	SM00135
Domain	Dynein_heavy_dom	DNAH2 DNAH6	7.12e-03	15	160	2	IPR004273
Domain	LDLR_classB_rpt	NID2 LRP6	7.12e-03	15	160	2	IPR000033
Domain	PHD	KMT2B PHF8 CXXC1 KMT2D	7.21e-03	89	160	4	SM00249
Domain	EGF-like_CS	NID2 MATN1 MATN2 ITGB4 LRP6 TNXB NOTCH2	7.34e-03	261	160	7	IPR013032
Domain	Ankyrin_rpt	ANK2 PPP1R13B DZANK1 GLS MPHOSPH8 NOTCH2 AGAP2	7.49e-03	262	160	7	IPR002110
Domain	WW	MAGI1 MAGI3 PCIF1	7.59e-03	47	160	3	PF00397
Domain	Znf_PHD	KMT2B PHF8 CXXC1 KMT2D	7.79e-03	91	160	4	IPR001965
Domain	WW	MAGI1 MAGI3 PCIF1	8.05e-03	48	160	3	SM00456
Domain	CBS	CLCNKA CLCNKB	8.09e-03	16	160	2	SM00116
Domain	Post-SET_dom	KMT2B KMT2D	8.09e-03	16	160	2	IPR003616
Domain	PostSET	KMT2B KMT2D	8.09e-03	16	160	2	SM00508
Domain	Guanylate_kinase_CS	MAGI1 MAGI3	8.09e-03	16	160	2	IPR020590
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZEB1 KMT2B MYCBP2 ZGRF1 MCM7 CHD7 HMG20B KIAA1671 NCOR1 KMT2D GTF3C1 ZNF608 AHNAK GLS SEC23IP GEMIN4 RCOR3 GPRASP2	1.86e-12	418	165	18	34709266
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF21B MAGI1 AMPD2 IQSEC3 CAD ZEB1 FMR1 ANK2 MYCBP2 MINK1 SPTBN2 TRIOBP DPYSL4 CHD7 CRMP1 KIAA0319 NCOR1 DZANK1 CNTNAP5 SEC23IP PRKCE FRMPD3 SLC4A4 EPB41L2 AGAP2	5.53e-12	963	165	25	28671696
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CAD KMT2B MYCBP2 SPTBN2 PPP1R13B MCM7 PHF8 SRCAP KIAA1671 NCOR1 KMT2D GTF3C1 ANLN AHNAK SEC23IP NONO RSBN1L HTT	1.62e-10	549	165	18	38280479
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	IQSEC3 FMR1 ANK2 MINK1 SPTBN2 CRMP1 DZANK1 AHNAK PRKCE PCDH1 EPB41L2 AGAP2	1.15e-08	281	165	12	28706196
Pubmed	Human transcription factor protein interaction networks.	CCDC8 CAD ZEB1 KMT2B FOS PPP1R13B CHD7 SSB PHF8 SRCAP CXXC1 SLC1A5 HMG20B NUP205 ZNF3 MRPS18A KIAA1671 NCOR1 KMT2D GTF3C1 ZNF608 SS18L1 LRP6 RCOR3 QKI	1.85e-08	1429	165	25	35140242
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ANK2 SPTBN2 DNAH2 MAGI3 BRD3 SRCAP CXXC1 NUP205 RPS6KC1 NCOR1 GTF3C1 ZNF608 SUGCT TCHHL1 AHNAK GLS SEC23IP MPHOSPH8 MYOM2 EIF4G3 SPAG17 DNAH6 NONO SLC25A31 AGAP2	2.21e-08	1442	165	25	35575683
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	AMPD2 IQSEC3 CAD FMR1 ANK2 MYCBP2 ATP13A1 MINK1 ETFB TRIOBP DGKG NDUFA2 RPS28 RPS6KC1 DZANK1 GLS MAP3K10 KCNQ2 SLC4A4 EIF4G3 EPB41L2 AGAP2	2.59e-08	1139	165	22	36417873
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RNF169 ZEB1 KMT2B MYCBP2 MINK1 BRD3 CHD7 PHF8 ADARB1 IWS1 NCOR1 KMT2D GTF3C1 ANLN RBM15B CCDC9 EPB41L2 NOTCH2	3.42e-08	774	165	18	15302935
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CAD MYCBP2 SPTBN2 TRIOBP DPYSL4 BRD3 CHD7 SRCAP CXXC1 CRMP1 NUP205 IWS1 ZSCAN29 GTF3C1 KIN SS18L1 RBM15B MPHOSPH8 NONO TNXB AQR	5.09e-08	1082	165	21	38697112
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	KMT2B SPTBN2 DNAH2 MAGI3 BRD3 PHF8 CXXC1 NUP205 RPS6KC1 KIAA1671 PARP4 GTF3C1 AHNAK ZNF408 PCIF1 CHRD EPB41L2	9.27e-08	736	165	17	29676528
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RNF169 THSD7A ATP13A1 SPTBN2 MAGI3 VARS2 RALGAPA2 CEP68 PARP4 SS18L1 GLS DIP2C DDHD2 DHTKD1	1.13e-07	493	165	14	15368895
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	METTL3 CAD EPPK1 FMR1 TRIM26 SPTBN2 MCM7 ITGB4 NUP205 KIAA1671 GTF3C1 KIN ANLN AHNAK GLS RBM15B GEMIN4 GAN NONO RSBN1L AQR EPB41L2	1.43e-07	1257	165	22	36526897
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ABCC1 RNF169 FMR1 KMT2B FOS BRD3 CHD7 RPS28 PHF8 SRCAP CXXC1 HMG20B IWS1 ZSCAN29 NCOR1 KMT2D GTF3C1 AHNAK RBM15B RCOR3 MPHOSPH8 NONO	2.35e-07	1294	165	22	30804502
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	RNF169 METTL3 CAD KMT2B ATP13A1 TRIM26 MINK1 TRIOBP BRD3 CHD7 RPS28 HMG20B IWS1 KIAA1671 ANLN RBM15B GEMIN4 MPHOSPH8 EIF4G3 NONO RSBN1L AQR EPB41L2	7.12e-07	1497	165	23	31527615
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAGI1 AMPD2 CCDC8 MYCBP2 MINK1 MAGI3 SLC1A5 KIAA1671 ANLN AHNAK MAP3K10 GAN PRKCE EIF4G3 AQR EPB41L2 NOTCH2	8.24e-07	861	165	17	36931259
Pubmed	Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.	NID2 CAD EPPK1 BRD3 IWS1 GTF3C1 GAN NONO EPB41L2	1.13e-06	219	165	9	31353912
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IQSEC3 CAD FMR1 ANK2 MINK1 SPTBN2 ETFB DPYSL4 SSB NDUFA2 JMY CRMP1 DZANK1 PPP2R2C KCNQ2 PRKCE SLC4A4 EIF4G3 DNAH6 PCDH1 EPB41L2 AGAP2	1.26e-06	1431	165	22	37142655
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	CCDC8 CAD FMR1 MYCBP2 MCM7 SSB SRCAP NUP205 RPS6KC1 GTF3C1 EIF2AK3 AQR	1.43e-06	440	165	12	34244565
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	FMR1 MCM7 BRD3 CHD7 NUP205 IWS1 KMT2D GTF3C1 AHNAK RCOR3 CCDC9 AQR	2.76e-06	469	165	12	27634302
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ABCC1 CCDC8 RNF169 CAD MYCBP2 MINK1 SPTBN2 TRIOBP PPP1R13B BRD3 PHF8 SLC1A5 IWS1 KIAA1671 NCOR1 KMT2D AHNAK LRP6	2.81e-06	1049	165	18	27880917
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CAD EPPK1 FMR1 MYCBP2 SPTBN2 CHD7 SSB NUP205 GTF3C1 AHNAK GEMIN4 EIF4G3 AQR EPB41L2	3.15e-06	653	165	14	22586326
Pubmed	Defining the membrane proteome of NK cells.	ABCC1 CAD FMR1 MYCBP2 ATP13A1 MCM7 SLC1A5 NUP205 TBC1D10C NCOR1 PARP4 GTF3C1 AHNAK GEMIN4 NONO EIF2AK3 AQR NOTCH2 AGAP2	3.17e-06	1168	165	19	19946888
Pubmed	Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.	USE1 CHD7 SLC1A5 AHNAK SEC23IP EIF2AK3 EPB41L2 NOTCH2	3.93e-06	191	165	8	31177093
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	AMPD2 RNF169 METTL3 CAD ITGB4 IWS1 NCOR1 GTF3C1 ANLN EIF4G3 NONO EPB41L2	5.62e-06	503	165	12	16964243
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	EPPK1 KMT2B MYCBP2 ATP13A1 SRCAP RALGAPA2 ITGB4 SLC1A5 SBNO2 NCOR1 KMT2D SGSM2 AHNAK ZNF408 DIP2C KCNQ2 NOTCH2 HTT	5.74e-06	1105	165	18	35748872
Pubmed	Claudin-4 localization in epithelial ovarian cancer.	SPTBN2 SLC1A5 AHNAK EPB41L2 NOTCH2	5.93e-06	54	165	5	36237976
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	MAGI1 CAD ANK2 MINK1 ETFB MAGI3 SLC1A5 AHNAK SEC23IP GEMIN4 LRP6 EIF4G3 EIF2AK3 EPB41L2	7.91e-06	708	165	14	39231216
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CCDC8 CAD ANK2 MYCBP2 USE1 ATP13A1 MINK1 SPTBN2 ETFB TRIOBP NDUFA2 VARS2 RPS28 SLC1A5 GLS DDHD2 EIF4G3 EIF2AK3 AQR EPB41L2 NOTCH2	8.28e-06	1487	165	21	33957083
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MAGI1 MYCBP2 TRIM26 MINK1 TRIOBP MAGI3 ADARB1 SBNO2 KIAA1671 PPP2R2C GTF3C1 ZNF608 SGSM2 DIP2C PRKCE RCOR3 SYTL1 EIF4G3 PCDH1 NOTCH2 HTT	8.45e-06	1489	165	21	28611215
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ANK2 MYCBP2 ATP13A1 SPTBN2 TRIOBP ZNF202 MAGI3 ADARB1 CRMP1 SGSM2 GLS SEC23IP MAP3K10 KCNQ2 EIF4G3 QKI GPRASP2 RSBN1L AGAP2	1.22e-05	1285	165	19	35914814
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	THSD7A MYCBP2 TRIOBP CHD7 PHF8 CEP68 ZNF608 DIP2C	1.30e-05	225	165	8	12168954
Pubmed	The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically.	TRIM26 BRD3 PHF8 PARP4 NONO	1.60e-05	66	165	5	32051553
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	ABCC1 NID2 AMPD2 ATP13A1 MATN2 ETFB MCM7 NDUFA2 VARS2 RPS28 EHD2 TCHHL1 MRC2 AHNAK GLS MAP3K10 DNAH6 NONO EPB41L2 NOTCH2	1.96e-05	1451	165	20	30550785
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	RNF169 TRIOBP ITGB4 ANLN AHNAK EIF4G3	2.21e-05	118	165	6	30979931
Pubmed	Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.	KMT2B CXXC1 KMT2D	2.24e-05	12	165	3	27563068
Pubmed	MAGI-1: a widely expressed, alternatively spliced tight junction protein.	MAGI1 MAGI3	2.24e-05	2	165	2	11969287
Pubmed	The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron.	CLCNKA CLCNKB	2.24e-05	2	165	2	27335120
Pubmed	Assignment of the genes encoding the human chloride channels, CLCNKA and CLCNKB, to 1p36 and of CLCN3 to 4q32-q33 by in situ hybridization.	CLCNKA CLCNKB	2.24e-05	2	165	2	8812470
Pubmed	Associations between CLCNKA_B tag SNPs with essential hypertension and interactions between genetic and environmental factors in an island population in China.	CLCNKA CLCNKB	2.24e-05	2	165	2	25919862
Pubmed	Disruption of PLZP in mice leads to increased T-lymphocyte proliferation, cytokine production, and altered hematopoietic stem cell homeostasis.	KMT2D ZBTB32	2.24e-05	2	165	2	15542853
Pubmed	Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4).	KMT2B KMT2D	2.24e-05	2	165	2	35640156
Pubmed	Hepatocyte NLRP3 interacts with PKCε to drive hepatic insulin resistance and steatosis.	NLRP3 PRKCE	2.24e-05	2	165	2	37336688
Pubmed	Activation of MLK2-mediated signaling cascades by polyglutamine-expanded huntingtin.	MAP3K10 HTT	2.24e-05	2	165	2	10801775
Pubmed	Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss.	CLCNKA CLCNKB	2.24e-05	2	165	2	38069401
Pubmed	CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping Conditions.	CHD7 KMT2D	2.24e-05	2	165	2	28475860
Pubmed	A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.	CLCNKA CLCNKB	2.24e-05	2	165	2	20805576
Pubmed	Salt wasting and deafness resulting from mutations in two chloride channels.	CLCNKA CLCNKB	2.24e-05	2	165	2	15044642
Pubmed	p125 is localized in endoplasmic reticulum exit sites and involved in their organization.	SEC23IP DDHD2	2.24e-05	2	165	2	15623529
Pubmed	Two highly homologous members of the ClC chloride channel family in both rat and human kidney.	CLCNKA CLCNKB	2.24e-05	2	165	2	8041726
Pubmed	Down-regulation of RalGTPase-Activating Protein Promotes Colitis-Associated Cancer via NLRP3 Inflammasome Activation.	RALGAPA2 NLRP3	2.24e-05	2	165	2	31622786
Pubmed	A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.	CLCNKA CLCNKB	2.24e-05	2	165	2	18648499
Pubmed	Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney.	CLCNKA CLCNKB	2.24e-05	2	165	2	8544406
Pubmed	Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse.	FMR1 ADARB1	2.24e-05	2	165	2	28640668
Pubmed	Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.	CLCNKA CLCNKB	2.24e-05	2	165	2	24863058
Pubmed	Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel.	CLCNKA CLCNKB	2.24e-05	2	165	2	9916798
Pubmed	Kidney kinetics and chloride ion pumps.	CLCNKA CLCNKB	2.24e-05	2	165	2	9916791
Pubmed	Huntingtin interacts with the receptor sorting family protein GASP2.	GPRASP2 HTT	2.24e-05	2	165	2	16835690
Pubmed	Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome.	FMR1 AGAP2	2.24e-05	2	165	2	25921541
Pubmed	Phosphorylation of glutaminase by PKCε is essential for its enzymatic activity and critically contributes to tumorigenesis.	GLS PRKCE	2.24e-05	2	165	2	29515166
Pubmed	MAGIs regulate aPKC to enable balanced distribution of intercellular tension for epithelial sheet homeostasis.	MAGI1 MAGI3	2.24e-05	2	165	2	33712709
Pubmed	Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders.	KMT2B KMT2D	2.24e-05	2	165	2	35506254
Pubmed	Primary structure and expression of matrilin-2, the closest relative of cartilage matrix protein within the von Willebrand factor type A-like module superfamily.	MATN1 MATN2	2.24e-05	2	165	2	9083061
Pubmed	Cl(-) channels in basolateral TAL membranes XV. Molecular heterogeneity between cortical and medullary channels.	CLCNKA CLCNKB	2.24e-05	2	165	2	11014860
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	CCDC8 MYCBP2 USE1 ATP13A1 ETFB SSB CXXC1 SLC1A5 KIAA1671 KIN GLS SEC23IP ZNF830 RSBN1L EPB41L2 NOTCH2	2.64e-05	1007	165	16	34597346
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	COL6A3 FMR1 ANK2 MYCBP2 SGCG NCOR1 PARP4 MLF1 RCOR3 MYOM2 NOTCH2	2.78e-05	497	165	11	23414517
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	KIF21B SPTBN2 BRD3 BEND4 RPS28 DNAI1 GTF3C1 ZNF408 GAN MYOM2 RSBN1L	2.78e-05	497	165	11	36774506
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	IQSEC3 ANK2 MINK1 SPTBN2 DZANK1 PRKCE EPB41L2 AGAP2	2.85e-05	251	165	8	27507650
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	CAD FMR1 MYCBP2 USE1 TRIM26 ETFB SSB NDUFA2 VARS2 MRPS18A KIAA1671 GLS PTAR1 SEC23IP MLF1 GEMIN4 DDHD2 QKI DHTKD1 EIF2AK3	3.01e-05	1496	165	20	32877691
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CCDC8 CAD EPPK1 MYCBP2 SPTBN2 ETFB MCM7 SRCAP SLC1A5 NUP205 KIAA1671 GTF3C1 AHNAK NONO AQR EPB41L2	3.22e-05	1024	165	16	24711643
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	KMT2B MATN2 ITGB4 CXXC1 NCOR1 DZANK1 ZBTB32 CHRD ZNF488 QKI EPB41L2 NOVA1	3.65e-05	608	165	12	16713569
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	FMR1 SPTBN2 SSB RPS28 MRPS18A GTF3C1 KIN RBM15B GEMIN4 QKI NONO RSBN1L AQR	3.90e-05	713	165	13	29802200
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	PHF8 SRCAP NUP205 NCOR1 KMT2D GTF3C1 GEMIN4 RSBN1L AQR	3.95e-05	341	165	9	32971831
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	KIF21B METTL3 ATP13A1 MINK1 ETFB MCM7 SSB CRMP1 PRKCE CCDC9 EPB41L2 HTT	4.48e-05	621	165	12	22794259
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	IQSEC3 ANK2 MYCBP2 MINK1 KCNQ2 PRKCE EIF4G3 HTT AGAP2	4.52e-05	347	165	9	17114649
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	ANK2 MCM7 ADARB1 ANLN AHNAK NONO AQR SLC25A31	4.90e-05	271	165	8	32433965
Pubmed	Interaction network of human early embryonic transcription factors.	ZEB1 KMT2B CHD7 HMG20B KIAA1671 NCOR1 KMT2D ZNF608 SS18L1	4.94e-05	351	165	9	38297188
Pubmed	Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.	CAD EPPK1 ITGB4 NCOR1 AHNAK	5.16e-05	84	165	5	25670202
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	CAD MYCBP2 SLC1A5 NUP205 LRP6 EIF4G3 AQR	5.38e-05	202	165	7	24639526
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	KIF21B ZGRF1 PARP3 SPTBN2 ETFB DNAH2 MCM7 RPS28 SRCAP MRPS18A EIF4G3 DNAH6 NONO EPB41L2	5.64e-05	847	165	14	35235311
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	CCDC8 CAD ANK2 MCM7 SSB RPS28 PHF8 IWS1 MRPS18A PARP4 GTF3C1 KIN QKI GPRASP2 AQR	6.52e-05	971	165	15	33306668
Pubmed	Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional.	CLCNKA CLCNKB	6.69e-05	3	165	2	26013830
Pubmed	Barttin increases surface expression and changes current properties of ClC-K channels.	CLCNKA CLCNKB	6.69e-05	3	165	2	12111250
Pubmed	Reduced mitochondrial fusion and Huntingtin levels contribute to impaired dendritic maturation and behavioral deficits in Fmr1-mutant mice.	FMR1 HTT	6.69e-05	3	165	2	30742117
Pubmed	Notch2 regulates the development of marginal zone B cells through Fos.	FOS NOTCH2	6.69e-05	3	165	2	22293205
Pubmed	Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.	KMT2D NOTCH2	6.69e-05	3	165	2	27566587
Pubmed	ZEB1 coordinately regulates laminin-332 and {beta}4 integrin expression altering the invasive phenotype of prostate cancer cells.	ZEB1 ITGB4	6.69e-05	3	165	2	20729552
Pubmed	Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance).	CHD7 KMT2D	6.69e-05	3	165	2	28007623
Pubmed	Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension.	CLCNKA CLCNKB	6.69e-05	3	165	2	17510212
Pubmed	Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.	MLF1 HTT	6.69e-05	3	165	2	27840155
Pubmed	Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.	FOS NCOR1	6.69e-05	3	165	2	17440114
Pubmed	Mutant huntingtin increases nuclear corepressor function and enhances ligand-dependent nuclear hormone receptor activation.	NCOR1 HTT	6.69e-05	3	165	2	12799135
Pubmed	Expression of matrilin-1, -2 and -3 in developing mouse limbs and heart.	MATN1 MATN2	6.69e-05	3	165	2	11102754
Pubmed	Barttin modulates trafficking and function of ClC-K channels.	CLCNKA CLCNKB	6.69e-05	3	165	2	16849430
Pubmed	DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia.	DNAI1 DNAH6	6.69e-05	3	165	2	26918822
Pubmed	Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer.	SLC1A5 GLS	6.69e-05	3	165	2	23507704
Pubmed	Mechanisms of Disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance.	CLCNKA CLCNKB	6.69e-05	3	165	2	18094726
Pubmed	Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Krüppel-like factor, a novel zinc finger repressor.	CLCNKA CLCNKB	6.69e-05	3	165	2	10982849
Pubmed	PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.	ABCC1 EIF2AK3	6.69e-05	3	165	2	28499449
Pubmed	PKC epsilon as a neonatal target to correct FXS-linked AMPA receptor translocation in the hippocampus, boost PVN oxytocin expression, and normalize adult behavior in Fmr1 knockout mice.	FMR1 PRKCE	6.69e-05	3	165	2	33359697
Pubmed	METTL3-deficiency m6A-dependently degrades MALAT1 to suppress NLRP3-mediated pyroptotic cell death and inflammation in Mycobacterium tuberculosis (H37Ra strain)-infected mouse macrophages.	METTL3 NLRP3	6.69e-05	3	165	2	38458103
Interaction	AGAP2 interactions	IQSEC3 FMR1 ANK2 MINK1 SPTBN2 CRMP1 AHNAK PRKCE PCDH1 EPB41L2 AGAP2	9.10e-07	210	159	11	int:AGAP2
Interaction	KDM1A interactions	ZEB1 FMR1 KMT2B MYCBP2 ZGRF1 MCM7 CHD7 PHF8 ADARB1 HMG20B KIAA1671 NCOR1 KMT2D GTF3C1 ZNF608 AHNAK GLS ZNF641 SEC23IP GEMIN4 RCOR3 GPRASP2 HTT	1.39e-06	941	159	23	int:KDM1A
Interaction	NEFM interactions	CAD EPPK1 FOS MINK1 MCM7 SSB NUP205 GAN HTT AGAP2	2.77e-06	190	159	10	int:NEFM
Interaction	TBR1 interactions	METTL3 MYCBP2 BRD3 CHD7 HMG20B NCOR1 KMT2D ZNF608	3.19e-06	113	159	8	int:TBR1
Interaction	PHF21A interactions	KMT2B MYCBP2 ZGRF1 MCM7 CHD7 HMG20B KIAA1671 KMT2D AHNAK SEC23IP GEMIN4 RCOR3 GPRASP2	3.47e-06	343	159	13	int:PHF21A
Interaction	IQSEC3 interactions	IQSEC3 MYCBP2 ANLN AGAP2	3.51e-06	14	159	4	int:IQSEC3
Interaction	TBXT interactions	CAD CHD7 HMG20B NCOR1 KMT2D ZNF608 SS18L1 RCOR3	3.89e-06	116	159	8	int:TBXT
Interaction	KIF21B interactions	KIF21B FMR1 MYCBP2 GAN QKI HTT	4.62e-06	55	159	6	int:KIF21B
Interaction	ASF1A interactions	RNF169 KMT2B FOS SPTBN2 MCM7 CHD7 SRCAP NCOR1 KMT2D GTF3C1 ANLN	4.75e-06	249	159	11	int:ASF1A
Interaction	FEV interactions	ZEB1 KMT2B CHD7 CXXC1 HMG20B NCOR1 KMT2D GTF3C1 ZNF608 SS18L1	5.00e-06	203	159	10	int:FEV
Interaction	SP7 interactions	CAD KMT2B CHD7 HMG20B NUP205 ZNF3 NCOR1 KMT2D ZNF608 SS18L1 RCOR3 QKI	5.53e-06	304	159	12	int:SP7
Interaction	PAX7 interactions	ZEB1 CHD7 HMG20B NCOR1 KMT2D ZNF608 SS18L1 RCOR3	6.38e-06	124	159	8	int:PAX7
Interaction	ZNF330 interactions	RNF169 KMT2B BRD3 CHD7 SSB PHF8 NUP205 IWS1 GTF3C1 KIN ANLN ZNF408 MPHOSPH8 RSBN1L	1.25e-05	446	159	14	int:ZNF330
Interaction	SMARCC2 interactions	CCDC8 CAD FMR1 MYCBP2 FOS BRD3 CHD7 SRCAP ADARB1 NCOR1 SS18L1 NOVA1	2.46e-05	353	159	12	int:SMARCC2
Interaction	FOXL1 interactions	ZEB1 CHD7 NUP205 NCOR1 KMT2D GTF3C1 ZNF608 RCOR3 NOVA1	2.62e-05	196	159	9	int:FOXL1
Interaction	SYNGAP1 interactions	FMR1 ANK2 MYCBP2 MINK1 SPTBN2 ETFB KCNQ2 PRKCE EIF4G3 EPB41L2 AGAP2	3.36e-05	307	159	11	int:SYNGAP1
Interaction	TNIK interactions	IQSEC3 CAD FMR1 ANK2 MYCBP2 MINK1 SPTBN2 PPP1R13B DZANK1 KCNQ2 HTT AGAP2	5.16e-05	381	159	12	int:TNIK
Interaction	PHF20 interactions	KMT2B TRIM26 CXXC1 ZNF608 HTT	6.07e-05	53	159	5	int:PHF20
Interaction	MATR3 interactions	CCDC8 METTL3 CAD EPPK1 FMR1 MYCBP2 DNAH2 NCOR1 GTF3C1 ANLN RBM15B PRKCE MPHOSPH8 NONO HTT NOVA1	6.36e-05	655	159	16	int:MATR3
Interaction	HNF4A interactions	KMT2B CHD7 SRCAP CXXC1 HMG20B NCOR1 KMT2D ZNF608 SS18L1 RCOR3	6.81e-05	275	159	10	int:HNF4A
Interaction	RHOA interactions	MAGI1 ABCC1 CCDC8 CAD EPPK1 USE1 ATP13A1 SPTBN2 ETFB VASH1 SLC1A5 CRMP1 NUP205 EHD2 ANLN MRC2 GLS SEC23IP GEMIN4 EIF2AK3 NOTCH2 HTT AGAP2	6.86e-05	1199	159	23	int:RHOA
Interaction	MECP2 interactions	CAD MYCBP2 SPTBN2 TRIOBP DPYSL4 BRD3 CHD7 SRCAP CXXC1 CRMP1 NUP205 IWS1 ZSCAN29 NCOR1 GTF3C1 KIN ANLN SS18L1 RBM15B MPHOSPH8 NONO TNXB AQR EPB41L2	7.30e-05	1287	159	24	int:MECP2
Interaction	SMARCA4 interactions	CAD ZEB1 FMR1 FOS BRD3 CHD7 SRCAP ADARB1 NCOR1 ANLN SS18L1 NONO EPB41L2	7.90e-05	462	159	13	int:SMARCA4
Interaction	NFIX interactions	ZEB1 KMT2B FOS SRCAP CXXC1 NCOR1 KMT2D GTF3C1 ZNF608	8.21e-05	227	159	9	int:NFIX
Interaction	MYB interactions	ZEB1 KMT2B CHD7 PHF8 CXXC1 NCOR1 KMT2D	9.03e-05	133	159	7	int:MYB
Interaction	H3C1 interactions	RNF169 KMT2B ANK2 DNAH2 MCM7 BRD3 CHD7 SSB PHF8 SRCAP NCOR1 KMT2D GTF3C1 ANLN AHNAK MPHOSPH8 ZNF830 RSBN1L AQR	9.21e-05	901	159	19	int:H3C1
Interaction	FLOT1 interactions	MAGI1 ABCC1 CCDC8 CAD ANK2 MINK1 SPTBN2 PPP1R13B SLC1A5 ANLN EPB41L2 NOTCH2 HTT	1.04e-04	475	159	13	int:FLOT1
Interaction	BAG2 interactions	METTL3 DNAH2 PPP1R13B BRD3 CXXC1 KIAA1671 NCOR1 PPP2R2C ANLN AHNAK MLF1 KCNQ2 EIF4G3 QKI HTT	1.25e-04	622	159	15	int:BAG2
Interaction	WWTR1 interactions	ZEB1 MYCBP2 PPP1R13B MCM7 SRCAP KIAA1671 NCOR1 KMT2D GTF3C1 ANLN SEC23IP HTT	1.36e-04	422	159	12	int:WWTR1
Interaction	NFIB interactions	METTL3 FOS HMG20B NCOR1 KMT2D ZNF608 RCOR3	1.36e-04	142	159	7	int:NFIB
Interaction	WDR77 interactions	METTL3 FMR1 TRIOBP RPS28 CXXC1 ANLN GAN QKI AQR EPB41L2 HTT	1.43e-04	361	159	11	int:WDR77
Interaction	PAX6 interactions	ZEB1 CHD7 SRCAP HMG20B NCOR1 KMT2D GTF3C1 ZNF608 SS18L1 RCOR3 EPB41L2	1.61e-04	366	159	11	int:PAX6
Interaction	APEX1 interactions	ABCC1 RNF169 ZEB1 KMT2B USE1 ATP13A1 TRIM26 SPTBN2 BRD3 CHD7 VARS2 PHF8 SRCAP ITGB4 NUP205 IWS1 GTF3C1 ANLN AHNAK EIF4G3 QKI RSBN1L EPB41L2	1.63e-04	1271	159	23	int:APEX1
Interaction	VWA5B1 interactions	TRIOBP VWA5B1	1.85e-04	3	159	2	int:VWA5B1
Interaction	GATA2 interactions	ZEB1 CHD7 HMG20B NCOR1 KMT2D ZBTB32 ZNF608 RCOR3	1.87e-04	199	159	8	int:GATA2
Interaction	CCT4 interactions	METTL3 CAD MYCBP2 MCM7 SSB EHD2 PPP2R2C PLAC8L1 ANLN SEC23IP B9D1 GAN HTT	2.31e-04	515	159	13	int:CCT4
Interaction	WDR76 interactions	NID2 CAD EPPK1 MCM7 BRD3 CHD7 IWS1 GTF3C1 GAN NONO EPB41L2	2.38e-04	383	159	11	int:WDR76
Interaction	EPX interactions	DNAH2 GAN DNAH6	2.50e-04	16	159	3	int:EPX
Interaction	PAX8 interactions	CHD7 HMG20B NCOR1 KMT2D ZNF608 SS18L1	2.51e-04	111	159	6	int:PAX8
Interaction	SUMO2 interactions	CAD EPPK1 TRIM26 FOS BRD3 PHF8 SRCAP NCOR1 GTF3C1 ANLN AHNAK RCOR3 NONO HTT	2.54e-04	591	159	14	int:SUMO2
Interaction	ASH2L interactions	KMT2B FOS CHD7 PHF8 SRCAP CXXC1 KMT2D RBM15B HTT	2.63e-04	265	159	9	int:ASH2L
Interaction	ARL15 interactions	CCDC8 MINK1 SLC1A5 CRMP1 AHNAK EPB41L2	2.77e-04	113	159	6	int:ARL15
Interaction	OBSL1 interactions	CCDC8 CAD EPPK1 SPTBN2 MCM7 PHF8 SRCAP CXXC1 NUP205 GTF3C1 SLC7A6OS AHNAK GEMIN4 NONO GPRASP2 RSBN1L AQR NOTCH2	2.80e-04	902	159	18	int:OBSL1
Interaction	RNF123 interactions	KMT2B SPTBN2 DNAH2 MAGI3 BRD3 PHF8 CXXC1 NUP205 RPS6KC1 KIAA1671 PARP4 GTF3C1 AHNAK ZNF408 PCIF1 CHRD EPB41L2	2.84e-04	824	159	17	int:RNF123
GeneFamily	Dyneins, axonemal	DNAH2 DNAI1 DNAH6	1.29e-04	17	107	3	536
GeneFamily	Ankyrin repeat domain containing	ANK2 PPP1R13B DZANK1 GLS MPHOSPH8 NOTCH2 AGAP2	5.91e-04	242	107	7	403
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	CCDC8 PPP1R13B MCM7 NCOR1 PCIF1 NONO	7.26e-04	181	107	6	694
GeneFamily	Chloride voltage-gated channels	CLCNKA CLCNKB	1.51e-03	10	107	2	302
GeneFamily	UPF1 like RNA helicases	ZGRF1 AQR	1.84e-03	11	107	2	1169
GeneFamily	PHD finger proteins	KMT2B PHF8 CXXC1 KMT2D	2.01e-03	90	107	4	88
GeneFamily	Zinc fingers CXXC-type	KMT2B CXXC1	2.20e-03	12	107	2	136
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	CHD7 NCOR1 RCOR3	3.81e-03	53	107	3	532
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	PARP3 PARP4	4.45e-03	17	107	2	684
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	KIF21B ZEB1 KMT2B TRIM26 CHD7 RALGAPA2 NUP205 IWS1 NCOR1 GTF3C1	2.14e-07	180	164	10	M8239
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	MAGI1 ZEB1 MAGI3 RALGAPA2 DIP2C PRKCE EIF4G3 QKI	1.18e-05	169	164	8	M39230
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NID2 COL6A3 ANK2 MRC2 CHRD CTSK TNXB EPB41L2 NOVA1	5.47e-08	197	165	9	71786e9432e2d649f5d86f639abb25e7102deb67
ToppCell	facs-Trachea-nan-3m-Mesenchymal-fibroblast\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ZEB1 MATN2 EHD2 MRC2 CTSK TNXB EPB41L2	7.76e-07	198	165	8	0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	NID2 COL6A3 ANK2 MATN2 MRC2 CTSK TNXB NOVA1	8.06e-07	199	165	8	07b8c33342c62afd9c63ec2d757cfa3ba65d2a98
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZEB1 CRMP1 EHD2 ZNF608 AHNAK PRKCE XAF1 NOVA1	8.37e-07	200	165	8	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BEND4 CHD7 ADARB1 ZNF608 C12orf42 PRKCE EIF2AK3 EPB41L2	8.37e-07	200	165	8	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 MATN2 MRC2 LRP6 SLC4A4 MDGA1 EPB41L2 NOTCH2	8.37e-07	200	165	8	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 ANK2 MRC2 CTSK TNXB EPB41L2 NOVA1	3.69e-06	172	165	7	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	COVID-19-kidney-CD-IC-A\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAGI1 THSD7A SPTBN2 CNTNAP5 CLCNKA CLCNKB VWA5B1	4.30e-06	176	165	7	45028197364c64e93e3ffe86aff773d47a477d49
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 CCDC8 SGCG CTSK TNXB EPB41L2 NOVA1	4.80e-06	179	165	7	dcd0a83f0592ae27f814d064b4791f84c3c86e64
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NID2 COL6A3 MATN2 MRC2 CHRD CTSK TNXB	4.98e-06	180	165	7	39ae8586efd91536e9ac6408d26de7e6d6237c41
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 ANK2 MRC2 CTSK TNXB EPB41L2 NOVA1	5.35e-06	182	165	7	d179b5deb07c20d49eb6c58d5a65904f8921de3a
ToppCell	COVID-19-kidney-CD-IC-A\|kidney / Disease (COVID-19 only), tissue and cell type	MAGI1 SPTBN2 MAGI3 CNTNAP5 CLCNKA CLCNKB VWA5B1	5.55e-06	183	165	7	5c7597a5b2bf6a481ca2c7e68560179214150fa0
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 FOS NCOR1 ZNF608 AHNAK EIF4G3 AQR	5.75e-06	184	165	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	droplet-Kidney-nan-21m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 MATN2 KCNQ4 MRC2 CTSK TNXB NOVA1	5.75e-06	184	165	7	3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd
ToppCell	droplet-Kidney-nan-21m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 MATN2 KCNQ4 MRC2 CTSK TNXB NOVA1	5.96e-06	185	165	7	33cc0e9d8b54cb7408b51235f2a70e044ebae04d
ToppCell	droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 MATN2 KCNQ4 MRC2 CTSK TNXB NOVA1	5.96e-06	185	165	7	9954fc85b183c1cc45c3c24e3dadc7984ee6f649
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQSEC3 SPTBN2 DGKG SGSM2 KCNQ2 PRKCE AGAP2	6.40e-06	187	165	7	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQSEC3 SPTBN2 DGKG SGSM2 KCNQ2 PRKCE AGAP2	6.40e-06	187	165	7	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQSEC3 SPTBN2 DGKG SGSM2 KCNQ2 PRKCE AGAP2	6.40e-06	187	165	7	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MAGI1 ANK2 SGCG PPP1R13B DGKG MYOM2 QKI	6.86e-06	189	165	7	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MAGI1 ANK2 DGKG DIP2C MYOM2 QKI EIF2AK3	6.86e-06	189	165	7	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MAGI1 ANK2 SGCG PPP1R13B DGKG MYOM2 QKI	7.10e-06	190	165	7	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	NID2 COL6A3 ZEB1 ANK2 FRMPD3 TNXB NOVA1	7.10e-06	190	165	7	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	droplet-Kidney-nan-3m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CCDC8 MATN2 DPYSL4 MRC2 CTSK TNXB	7.10e-06	190	165	7	2abeb013bb83c578e67dcb985ba44ca63134950b
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	MAGI1 ANK2 SGCG PPP1R13B DGKG MYOM2 QKI	7.10e-06	190	165	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	MAGI1 ANK2 SGCG PPP1R13B DGKG MYOM2 QKI	7.34e-06	191	165	7	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ZEB1 THSD7A MATN2 MRC2 CHRD TNXB	7.60e-06	192	165	7	671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	MAGI1 ANK2 SGCG PPP1R13B DGKG MLF1 MYOM2	7.60e-06	192	165	7	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	NID2 COL6A3 ZEB1 MRC2 TNXB EPB41L2 NOVA1	7.60e-06	192	165	7	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ZEB1 THSD7A MATN2 MRC2 CHRD TNXB	7.60e-06	192	165	7	840a34c1b82d218be999ab5e1bcafd6370d7a4b1
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	COL6A3 ANK2 MATN2 MRC2 TNXB EPB41L2 NOVA1	7.60e-06	192	165	7	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI1 ZEB1 THSD7A VASH1 KIAA1671 ZNF608 PRKCE	7.86e-06	193	165	7	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 ANK2 MATN2 MRC2 CTSK TNXB NOVA1	8.13e-06	194	165	7	35b30bc954750e939f81a9a7498b8bc2ce69a299
ToppCell	Mesenchymal_cells-Arteriolar_fibro.\|World / Lineage and Cell class	COL6A3 ANK2 MATN2 MRC2 AHNAK CTSK TNXB	8.13e-06	194	165	7	c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MAGI1 ANK2 SGCG PPP1R13B ZNF608 MLF1 MYOM2	8.13e-06	194	165	7	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	MAGI1 ANK2 SGCG PPP1R13B ZNF608 MLF1 MYOM2	8.13e-06	194	165	7	c3535f7cc0076653c72db582047cff053c322397
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 ANK2 MRC2 CTSK TNXB EPB41L2 NOVA1	8.41e-06	195	165	7	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NID2 COL6A3 DGKG CRMP1 EHD2 KCNQ4 CHRD	8.69e-06	196	165	7	9d18381d7aaa063094a5df769a04c73350471525
ToppCell	3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NID2 COL6A3 DGKG CRMP1 EHD2 KCNQ4 CHRD	8.69e-06	196	165	7	a52cb512c6173be92aa9c4d96e2abbc32f45478d
ToppCell	3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NID2 COL6A3 DGKG CRMP1 EHD2 KCNQ4 CHRD	8.69e-06	196	165	7	afddacc0fb8b9c73dad5333137deb471a6ebdc06
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-tip_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MAGI1 NID2 THSD7A VASH1 EHD2 KIAA1671 PCDH1	8.98e-06	197	165	7	b212ff28ca2d1fea4140f186ab90941bdca21249
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COL6A3 ANK2 MATN2 SERTAD4-AS1 EHD2 MRC2 CTSK	9.28e-06	198	165	7	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN2 RPS28 ITGB4 EHD2 AHNAK QKI NONO	9.28e-06	198	165	7	22559b161e67b49fe8028bfaf861e069063599f5
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COL6A3 ANK2 EHD2 MRC2 CTSK EPB41L2 NOVA1	9.59e-06	199	165	7	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	368C-Fibroblasts-Fibroblast-D-\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 ANK2 MATN2 MRC2 CTSK TNXB NOVA1	9.59e-06	199	165	7	5a425e7d11c5911ff5855c27a7f058a7ed7abbb0
ToppCell	metastatic_Brain-Fibroblasts-FB-like_cells\|metastatic_Brain / Location, Cell class and cell subclass	NID2 COL6A3 CCDC8 ZEB1 MRC2 CTSK TNXB	9.59e-06	199	165	7	12133087eae9f0e9b6c13a71e8187117768e64ce
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZEB1 CRMP1 EHD2 PRKCE PCDH1 TNXB EPB41L2	9.59e-06	199	165	7	7ed541309808f15d65a9c4b26be2050e077539e6
ToppCell	368C-Fibroblasts-Fibroblast-D\|368C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 ANK2 MATN2 MRC2 CTSK TNXB NOVA1	9.59e-06	199	165	7	66545eb7f65e450b742628fd431956e13330a0d3
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NID2 COL6A3 ANK2 MYCBP2 ADARB1 MRC2 TNXB	9.59e-06	199	165	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZEB1 ANK2 MATN2 MRC2 TNXB EPB41L2 NOVA1	9.59e-06	199	165	7	9c2db0bb94cba71a3cc1827844da090e213e0258
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAGI1 THSD7A MCM7 CHD7 MAGEF1 CRMP1 NOVA1	9.59e-06	199	165	7	94baf00dad27964392c3fc34970a4e79d576d0d3
ToppCell	(5)_Fibroblast-D\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	NID2 COL6A3 ANK2 MATN2 CTSK TNXB NOVA1	9.59e-06	199	165	7	3f415620ad8b8d8c6871e1353e13f87b281fcc0e
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	COL6A3 ZEB1 FOS MATN2 AHNAK QKI EPB41L2	9.91e-06	200	165	7	5ba4ed490c64b3bb738e7729669f893fa73aa56f
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	COL6A3 ANK2 MRC2 CHRD CTSK TNXB NOVA1	9.91e-06	200	165	7	2022df85df94ab8cbb4e80e3fe9894c01051c5e0
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SOX30 DNAH2 ODAD4 KIAA0319 DNAI1 SPAG17 DNAH6	9.91e-06	200	165	7	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	3'-Parenchyma_lung-Mesenchymal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 ANK2 MRC2 CHRD CTSK TNXB NOVA1	9.91e-06	200	165	7	ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833
ToppCell	Bronchus_Control_(B.)-Stromal-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	COL6A3 ANK2 MRC2 CHRD CTSK TNXB NOVA1	9.91e-06	200	165	7	69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 ANK2 MRC2 CHRD CTSK TNXB NOVA1	9.91e-06	200	165	7	14f3fe19b6647b32a5e28d717235741997d8522c
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 ZEB1 ANK2 MRC2 TNXB EPB41L2 NOVA1	9.91e-06	200	165	7	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZEB1 CRMP1 EHD2 AHNAK PRKCE PCDH1 NOVA1	9.91e-06	200	165	7	7034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	COL6A3 ANK2 CHRD CTSK TNXB EPB41L2 NOVA1	9.91e-06	200	165	7	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NID2 COL6A3 ZEB1 MRC2 TNXB EPB41L2 NOVA1	9.91e-06	200	165	7	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 ZEB1 ANK2 MRC2 TNXB EPB41L2 NOVA1	9.91e-06	200	165	7	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	KIF21B SRCAP KIAA1671 AHNAK XAF1 MYOM2 EIF4G3	9.91e-06	200	165	7	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 ANK2 MRC2 CHRD CTSK TNXB NOVA1	9.91e-06	200	165	7	5c6520dc4c4693827f6680651785680b5883afb8
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 ZEB1 ANK2 MATN2 TNXB EPB41L2 NOVA1	9.91e-06	200	165	7	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 ZEB1 ANK2 MRC2 TNXB EPB41L2 NOVA1	9.91e-06	200	165	7	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	mild-B_naive\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BEND4 CHD7 ADARB1 ZNF608 C12orf42 EIF2AK3 EPB41L2	9.91e-06	200	165	7	d0467cab6a42bf780aa49046bf3231ca161dc144
ToppCell	Ciliated_cells-B-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	SOX30 DNAH2 ODAD4 DNAI1 DZANK1 SPAG17	1.98e-05	149	165	6	6399c5a2f06d79f020dece252526f1c0c110d569
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 SPTBN2 MAGI3 CLCNKA CLCNKB VWA5B1	2.05e-05	150	165	6	87968ce885a4959616f0321f58517fe8029ba1b1
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|367C / Donor, Lineage, Cell class and subclass (all cells)	VARS2 NCR3 TBC1D10C GTF3C1 APRG1 SYTL1	2.38e-05	154	165	6	a39877cdf7b441b5c953f744ed30f1d5acf4ea19
ToppCell	COVID-CD4-CD4_Treg\|COVID / Condition, Cell_class and T cell subcluster	AMPD2 ZEB1 ZNF202 ZBED10P CXXC1 KMT2D	2.85e-05	159	165	6	037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	KIF21B ANK2 DGKG PPP2R2C CNTNAP5 AGAP2	3.51e-05	165	165	6	9795ce31689bc63f5a2d68725ef00b23a90c3846
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	ODAD4 DNAI1 MLF1 B9D1 SPAG17 DNAH6	3.75e-05	167	165	6	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIAA0319 DNAI1 CLCNKA SPAG17 DNAH6 NOVA1	4.01e-05	169	165	6	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VARS2 ITPRID1 PPP2R2C ZBTB32 ANLN KCNQ4	4.01e-05	169	165	6	96a2aec9acf8a6f966973c035e5ade456cf47772
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	AMPD2 TRIOBP MCM7 PHF8 RPS6KC1 PARP4	4.15e-05	170	165	6	09bcbc7eb3b1d35cf03f01ce2f2fe37373382dd4
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell\|5w / Sample Type, Dataset, Time_group, and Cell type.	AMPD2 KMT2B PARP3 NUP205 DNAH6 CTSK	4.57e-05	173	165	6	d4cbeae262abfa30d8c5452285d3261a96875610
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 SPTBN2 MAGI3 ITPRID1 CNTNAP5 VWA5B1	4.57e-05	173	165	6	0bc2aacae60c6d3276b0949eb0748b4ac1f56e54
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|356C / Donor, Lineage, Cell class and subclass (all cells)	USE1 MATN1 SRCAP ADARB1 MAP3K10 AGAP2	4.57e-05	173	165	6	e3cb7c8c09f937da6b8d673e9adfec5d94a15548
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 SPTBN2 MAGI3 CNTNAP5 DIP2C VWA5B1	4.87e-05	175	165	6	1d8da48236549c01381f777ce5b2937f9f86acc2
ToppCell	NS-moderate-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ANK2 ZBED10P CLCNKA CLCNKB DIP2C NOVA1	4.87e-05	175	165	6	a1e0a15c69211d6db2edeb101476f0f6e08b90c8
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF169 FOS CHD7 RPS28 GLS NOTCH2	4.87e-05	175	165	6	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 SPTBN2 MAGI3 CNTNAP5 CLCNKB VWA5B1	5.03e-05	176	165	6	25ebc8716aa44e44fce577701e3e82c6745a75ab
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	MAGI1 THSD7A RALGAPA2 KIAA1671 TNXB EPB41L2	5.03e-05	176	165	6	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	MAGI1 THSD7A RALGAPA2 KIAA1671 TNXB EPB41L2	5.03e-05	176	165	6	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	Control\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZEB1 CRMP1 KIAA1671 AHNAK PRKCE NOVA1	5.19e-05	177	165	6	b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	USE1 MATN1 VARS2 SRCAP MAP3K10 AGAP2	5.19e-05	177	165	6	36b5d29caa9cffbc0284f771a4db71aa72171a89
ToppCell	NS-moderate-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ANK2 CNTNAP5 CLCNKA CLCNKB ZNF488 NOVA1	5.70e-05	180	165	6	8af8b4af2dc72223ac71fc027e0d4280c5dd81f8
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	ZEB1 ITPRID1 KIAA1671 PRKCE PCDH1 EPB41L2	5.70e-05	180	165	6	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ZEB1 RALGAPA2 CRMP1 PRKCE XAF1 PCDH1	5.70e-05	180	165	6	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	USE1 MATN1 SRCAP ADARB1 MAP3K10 AGAP2	5.70e-05	180	165	6	a682a5d55c612709c9ee9fa4289d6f8bef7fe1af
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZEB1 CRMP1 EHD2 AHNAK PRKCE NOVA1	5.70e-05	180	165	6	544fb373a3346186ec60afe2cfcf141bb04a1eed
ToppCell	NS-critical-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	THSD7A ANK2 MAGEF1 CLCNKA CTSK PCDH1	5.88e-05	181	165	6	cfc3ed541d93158ce26641ea30b7573d93600a11
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ODAD4 KIAA0319 DNAI1 DZANK1 SPAG17 DNAH6	5.88e-05	181	165	6	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	DNAH2 ODAD4 KIAA0319 DNAI1 SPAG17 DNAH6	6.06e-05	182	165	6	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 CCDC8 MATN2 MRC2 TNXB NOVA1	6.06e-05	182	165	6	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 MATN2 SLC1A5 CLCNKB MRC2 TNXB	6.06e-05	182	165	6	f4b74c2756989812abe4e7055ec8918f69d56025
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NID2 COL6A3 ZEB1 TNXB EPB41L2 NOVA1	6.06e-05	182	165	6	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ZEB1 MRC2 CTSK TNXB NOVA1	6.63e-05	185	165	6	3cd0686a14e734a0f243070ab939adcb4c454478
Drug	Carbimazole [22232-54-8]; Down 200; 21.4uM; HL60; HT_HG-U133A	KMT2B SGCG PARP3 DGKG ZNF202 ADARB1 MAGEF1 LRP6 NOTCH2 AGAP2	1.56e-06	196	163	10	2437_DN
Drug	2,4,4'-trichlorobiphenyl	KIF21B MAGI1 COL6A3 IQSEC3 CCDC8 ZEB1 TRIOBP DGKG BEND4 NDUFA2 ITPRID1 RALGAPA2 SLC1A5 NUP205 IWS1 RPS6KC1 KIN SGSM2 GLS KCNQ2 PRKCE RCOR3 FRMPD3 MDGA1 NOVA1 AGAP2	8.31e-06	1411	163	26	ctd:C081766
Drug	2,4,5,2',5'-pentachlorobiphenyl	KIF21B MAGI1 COL6A3 IQSEC3 CCDC8 ZEB1 TRIOBP DGKG BEND4 NDUFA2 ITPRID1 RALGAPA2 SLC1A5 NUP205 IWS1 RPS6KC1 KIN SGSM2 GLS KCNQ2 PRKCE RCOR3 FRMPD3 MDGA1 NOVA1 AGAP2	1.20e-05	1441	163	26	ctd:C009828
Drug	Asiaticoside [16830-15-2]; Up 200; 4.2uM; PC3; HT_HG-U133A	VASH1 PPP1R13B CEP68 DZANK1 ZNF408 GLS SEC23IP QKI CCDC9	1.29e-05	197	163	9	7244_UP
Drug	(S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; HL60; HT_HG-U133A	ZEB1 SRCAP NLRP3 PCIF1 MLF1 LRP6 SLC4A4 NOTCH2 HTT	1.34e-05	198	163	9	2961_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	EPPK1 KMT2B MINK1 TRIOBP CHD7 SRCAP SLC1A5 SUGCT SGSM2	1.34e-05	198	163	9	2069_DN
Drug	Furosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A	KIF21B PARP3 NDUFA2 ADARB1 SBNO2 EHD2 MRC2 PRKCE CTSK	1.39e-05	199	163	9	6841_UP
Drug	Midecamycin [35457-80-8]; Up 200; 5uM; PC3; HG-U133A	ABCC1 PPP1R13B ADARB1 SBNO2 ZNF3 SEC23IP PCIF1 EPB41L2 NOVA1	1.45e-05	200	163	9	1943_UP
Disease	nephrogenic diabetes insipidus (implicated_via_orthology)	CLCNKA CLCNKB SLC4A4	1.76e-05	10	158	3	DOID:12387 (implicated_via_orthology)
Disease	cigarettes per day measurement	MAGI1 THSD7A PPP1R13B DGKG BEND4 DUS3L ADARB1 SGSM2 ZNF408 EIF4G3 CCDC9	2.59e-05	438	158	11	EFO_0006525
Disease	Bartter disease type 4B	CLCNKA CLCNKB	2.85e-05	2	158	2	cv:C4310805
Disease	Bartter disease type 3 (implicated_via_orthology)	CLCNKA CLCNKB	2.85e-05	2	158	2	DOID:0110144 (implicated_via_orthology)
Disease	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	CLCNKA CLCNKB	2.85e-05	2	158	2	613090
Disease	BARTTER SYNDROME, TYPE 4B	CLCNKA CLCNKB	2.85e-05	2	158	2	C2751312
Disease	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	CLCNKA CLCNKB	2.85e-05	2	158	2	C4310805
Disease	Bartter disease type 4b (is_implicated_in)	CLCNKA CLCNKB	2.85e-05	2	158	2	DOID:0110146 (is_implicated_in)
Disease	Bartter disease (implicated_via_orthology)	CLCNKA CLCNKB	2.85e-05	2	158	2	DOID:445 (implicated_via_orthology)
Disease	hereditary spastic paraplegia 28 (implicated_via_orthology)	SEC23IP DDHD2	8.52e-05	3	158	2	DOID:0110779 (implicated_via_orthology)
Disease	hereditary spastic paraplegia 54 (implicated_via_orthology)	SEC23IP DDHD2	8.52e-05	3	158	2	DOID:0110806 (implicated_via_orthology)
Disease	prostate carcinoma	COL6A3 ANK2 PPP1R13B CHD7 MAGEF1 CRMP1 MRPS18A CLCNKB SUGCT ANLN DIP2C PRKCE SYTL1 CTSK	3.27e-04	891	158	14	EFO_0001663
Disease	renal overload-type gout	SPATA31C2 SPATA31C1	4.21e-04	6	158	2	EFO_0021525
Disease	Bartter syndrome	CLCNKA CLCNKB	4.21e-04	6	158	2	cv:C0004775
Disease	neutrophil count	MAGI1 MYCBP2 ATP13A1 DGKG MAGI3 BRD3 CHD7 NLRP3 SBNO2 MRPS18A GTF3C1 FGFBP3 SLC4A4 CTSK TNXB CCDC9 NOTCH2 HTT	4.54e-04	1382	158	18	EFO_0004833
Disease	pentachlorophenol measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022071
Disease	parathion measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022070
Disease	potassium chromate measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022072
Disease	mercuric chloride measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022068
Disease	heptachlor epoxide measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022067
Disease	methoxychlor measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022052
Disease	azinphos methyl measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022055
Disease	aldrin measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022054
Disease	dicofol measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022060
Disease	disulfoton measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022062
Disease	dieldrin measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022061
Disease	endrin measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022064
Disease	endosulfan measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022063
Disease	heptachlor measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022066
Disease	ethion measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022065
Disease	chlorpyrifos measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022057
Disease	cadmium chloride measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022056
Disease	diazinon measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022059
Disease	dibutyl phthalate measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0022058
Disease	environmental exposure measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.46e-04	73	158	4	EFO_0008360
Disease	DDT metabolite measurement	ABCC1 NLRP3 CNTNAP5 XAF1	6.80e-04	74	158	4	EFO_0007886
Disease	eosinophil cationic protein measurement	SPATA31C2 SPATA31C1	7.81e-04	8	158	2	EFO_0010913
Disease	longitudinal alcohol consumption measurement	SPATA31C2 SPATA31C1	1.00e-03	9	158	2	EFO_0007645
Disease	response to anticonvulsant	ABCC1 COL6A3 THSD7A ANK2	1.14e-03	85	158	4	GO_0036277
Disease	body weight	NID2 METTL3 SPATA31C2 DGKG DPYSL4 CHD7 SERTAD4-AS1 SPATA31C1 SBNO2 NCR3 NCOR1 ANLN PRKCE QKI EIF2AK3 EPB41L2	1.25e-03	1261	158	16	EFO_0004338
Disease	long QT syndrome (implicated_via_orthology)	KCNQ4 KCNQ2	1.25e-03	10	158	2	DOID:2843 (implicated_via_orthology)
Disease	mean reticulocyte volume	ABCC1 CAD SGCG DNAH2 SBNO2 NUP205 GTF3C1 KIN SEC23IP PCIF1 RCOR3 EPB41L2	1.29e-03	799	158	12	EFO_0010701
Disease	psychosocial stress measurement	MATN1 AQR	1.52e-03	11	158	2	EFO_0006783
Disease	egg allergy measurement, parental genotype effect measurement	SPATA31C2 SPATA31C1	2.14e-03	13	158	2	EFO_0005939, EFO_0007018
Disease	developmental and epileptic encephalopathy (implicated_via_orthology)	KCNQ4 KCNQ2	2.14e-03	13	158	2	DOID:0112202 (implicated_via_orthology)
Disease	C-reactive protein measurement	CAD ZEB1 SGCG ETFB BRD3 CHD7 ADARB1 JMY NLRP3 ZNF3 NCOR1 ZNF608 AHNAK PCIF1 EIF4G3	2.14e-03	1206	158	15	EFO_0004458
Disease	blood cobalt measurement	ABCC1 NLRP3 CNTNAP5 XAF1	2.16e-03	101	158	4	EFO_0007577
Disease	Crohn's disease	KIF21B THSD7A ANK2 FOS MAGI3 SBNO2 NCR3 NOTCH2	2.68e-03	441	158	8	EFO_0000384
Disease	vital capacity	COL6A3 SPTBN2 CHD7 MAGEF1 JMY NCR3 NCOR1 SUGCT MRC2 LRP6 EIF2AK3 TNXB VWA5B1 EPB41L2 SLC25A31	2.71e-03	1236	158	15	EFO_0004312
Disease	Opioid use measurement	BEND4 MYOM2	2.86e-03	15	158	2	EFO_0009937
Disease	chronotype measurement	ANK2 MYCBP2 ETFB DGKG DUS3L CNTNAP5 KMT2D GLS DIP2C EIF4G3 MDGA1 EIF2AK3	2.91e-03	882	158	12	EFO_0008328
Disease	Peripheral Nervous System Diseases	ABCC1 GAN PRKCE	3.06e-03	54	158	3	C4721453
Disease	Spermatogenic Failure, Nonobstructive, Y-Linked	CDY1 CDY2A	3.25e-03	16	158	2	C1839071
Disease	Spermatogenic failure, Y-linked, 2	CDY1 CDY2A	3.25e-03	16	158	2	cv:C1839071
Disease	amygdala volume change measurement	SPATA31C2 SPATA31C1	3.25e-03	16	158	2	EFO_0021490
Disease	SPERMATOGENIC FAILURE, Y-LINKED, 2	CDY1 CDY2A	3.25e-03	16	158	2	415000
Disease	R-6-hydroxywarfarin measurement	ABCC1 DNAH2 CLCNKB AQR	3.35e-03	114	158	4	EFO_0803327
Disease	MAJOR AFFECTIVE DISORDER 2	MAGI1 KCNQ2	3.68e-03	17	158	2	C1839839
Disease	Dystonia, Limb	COL6A3 KMT2B	3.68e-03	17	158	2	C0751093
Disease	Dystonia, Diurnal	COL6A3 KMT2B	3.68e-03	17	158	2	C0393610
Disease	sex interaction measurement, ulcerative colitis	TRIM26 TNXB	3.68e-03	17	158	2	EFO_0000729, EFO_0008343
Disease	blood nickel measurement	ABCC1 NLRP3 CNTNAP5 XAF1	4.02e-03	120	158	4	EFO_0007583
Disease	Dystonia, Paroxysmal	COL6A3 KMT2B	4.12e-03	18	158	2	C0393588
Disease	autoimmune thyroid disease, type 1 diabetes mellitus	MAGI3 NCR3	4.12e-03	18	158	2	EFO_0006812, MONDO_0005147
Disease	X-11470 measurement	VARS2 TNXB	4.59e-03	19	158	2	EFO_0021241
Disease	Colorectal Carcinoma	ABCC1 CAD ANK2 SPTBN2 ITPRID1 DIP2C PRKCE XAF1 SPAG17 QKI	4.68e-03	702	158	10	C0009402
Disease	age at menarche	ETFB DNAH2 ZNF75CP RPS6KC1 DZANK1 ZBTB32 SEC23IP GAN EIF4G3	4.86e-03	594	158	9	EFO_0004703

Protein segments in the cluster

Peptide	Gene	Start	Entry
VIKVERPGAGDDTRT	SUGCT	76	Q9HAC7
KRAVARVGPVSVAID	CTSK	236	P43235
RVIASVGRKPVDGTR	C2orf16	1366	Q68DN1
TGDKGGRVVIFQREP	PPP2R2C	41	Q9Y2T4
KQAKVVARRESGGRP	BRD3	271	Q15059
RNITGTRVKVPVGQE	SLC1A5	211	Q15758
AVDRRGGPLVAKETV	ADAL	146	Q6DHV7
SVPRVKGGQRNITDD	CDY1	246	Q9Y6F8
TSVPRVKGGQRNITD	CDY2A	246	Q9Y6F7
QERAEPRGGSLAKVS	CEP68	211	Q76N32
TQKTVRAVGPRSGNE	EIF2AK3	241	Q9NZJ5
RGVAGLRDGKEVTPV	ATP13A1	546	Q9HD20
KRGGARGQQPEAIRT	EHD2	6	Q9NZN4
KRKRSVQSGETGPER	BEND4	436	Q6ZU67
VSTGREGQTPKAGLR	AHNAK	316	Q09666
RGETTGSGRAIPIKQ	AGAP2	666	Q99490
RVGDSNPIAKGRVAI	CLDN19	106	Q8N6F1
VQKREGTDSIPAAGR	APRG1	81	Q8IVJ8
IGRPNKVTTVDRFQG	AQR	1251	O60306
QVGNLIPKDSDEGRR	DNAI1	106	Q9UI46
AEPGEQLQTQKRARG	DUS3L	91	Q96G46
TKEGPEGNDIRRTNV	AMPD2	821	Q01433
EAVNPVAVGKTRGRQ	DHTKD1	291	Q96HY7
LTGEERVPVVNKRNG	CHD7	2641	Q9P2D1
GEKRTENGVGNPRVE	PPP1R13B	111	Q96KQ4
EQPVQTSKIGLGRRE	RCOR3	186	Q9P2K3
LDEVTRRIKQGSPNG	RBM15B	776	Q8NDT2
EPSGVLGAVATKVRR	QKI	306	Q96PU8
TGGQTPRRDLEKVLT	IWS1	721	Q96ST2
DPRREGGDQRVKSVI	GLS	541	O94925
EKGTEGRTGPVAVRE	NUP205	1041	Q92621
AQEAVVKVDRGPVRT	PARP3	161	Q9Y6F1
QVRRGLEGKEQEVPT	KIN	176	O60870
LPVTGTAESKRGVRV	ANK2	2056	Q01484
KGRAVVTVREGSPAE	MDGA1	446	Q8NFP4
TRRSLPGEQEQEVAG	NOTCH2	1606	Q04721
ARREKGAASNVAEPV	FGFBP3	26	Q8TAT2
PSSTLQKERVGGEER	MAP3K10	561	Q02779
RAVVIVDDRGRPSGK	NONO	176	Q15233
EGGRSRSPDISKVVI	MATN1	136	P21941
GRPQDSVAEVAAKAR	MATN2	171	O00339
TASQERPKEELGAGR	MAGEF1	31	Q9HAY2
PASGLSKGEREREIN	MAGI1	811	Q96QZ7
VENGVTRRGRSVSPK	MAGI3	1211	Q5TCQ9
EPEKGVVSVQERIRG	KIAA1671	471	Q9BY89
EVGEGRVKRGPSQTT	JMY	736	Q8N9B5
NGATGPVKRAREETD	SSB	376	P05455
FRDEVVPGKEVRNGT	NCR3	56	O14931
QSIGRRGKVEQLSPE	FOS	121	P01100
PNRAEEKAGGESVQR	ITPRID1	226	Q6ZRS4
TGKVSADLGPRERAV	GPR179	1731	Q6PRD1
GVQGESSPTRREAVK	RPS6KC1	276	Q96S38
LGVTPDKITNSGQRR	PRKCE	306	Q02156
GKFQRTRVPRAESGD	ANLN	646	Q9NQW6
TRVDQIVGRGPGDRK	KCNQ4	581	P56696
VVQDGDGRREVRSPT	EPB41L2	586	O43491
QIVGRGPAITDKDRT	KCNQ2	591	O43526
DRGTNPKSARAQVVV	PCDH1	361	Q08174
ERKRRAQEQGVAGPE	KIF21B	126	O75037
TEQGRPRTVKRGVEN	DDHD2	186	O94830
RSVGVVLKGEQDRPR	LRP6	1046	O75581
ISKPGTLERGDQTRS	MRC2	141	Q9UBG0
GAVKQISDRGPVRSE	KMT2B	831	Q9UMN6
PKVVEDRGVQRTDVG	PARP4	456	Q9UKK3
RTKIESGEGTIPVRS	ADARB1	521	P78563
TSGAPGVEKARNIVR	RALGAPA2	716	Q2PPJ7
GKGVLSRRPENETVL	IQSEC3	176	Q9UPP2
PVIRRVLDGGKSQVS	ITGB4	1011	P16144
PKDVIGRGVSSVVRR	PHKG2	26	P15735
GDKGQTARTQRPADV	MCM7	646	P33993
PGEVAGTVTGQKRRA	METTL3	166	Q86U44
TVPGGKGQERRSVTI	OVOL3	36	O00110
KDGREVQGTRSQPGT	NID2	1066	Q14112
NRAVIRESRKGVTDP	DGKG	676	P49619
QAKRRGVVVFGEPIT	DPYSL4	266	O14531
TRLGVDIGKGPEERQ	SLC25A31	151	Q9H0C2
GVKRPRRVVEDEGSS	CCDC82	206	Q8N4S0
QPSQKLGRIREDEGA	CXXC1	246	Q9P0U4
AATRPRAKEVGISEG	DNAH6	2541	Q9C0G6
PREAKGRTTDGSLQI	FMR1	566	Q06787
GGKNVLVPDRDVRVS	HTT	696	P42858
RKRQLSEEQPSGNGV	PCIF1	111	Q9H4Z3
ELEGVAVTAPRKGRS	CCDC9	46	Q9Y3X0
RKLPQSEGQVQGERT	FRMPD3	891	Q5JV73
VTVGGEERVSRKPTA	GAN	276	Q9H2C0
PDGTIVRVQRDGNKL	CENPJ	1266	Q9HC77
DDVRNPSVVVKRGGA	COL6A3	1146	P12111
DIGVIPINSRGEKQR	DIP2C	1521	Q9Y2E4
TVEKNSRPQEGTGRR	KLF17	261	Q5JT82
PRSDVGTKRDIGTQT	DZANK1	421	Q9NVP4
DPKVVAQGEGREVTR	B9D1	146	Q9UPM9
RRRKEQTAPTGQGAD	CCDC8	276	Q9H0W5
TPTRAGGQTREEKVL	DNAH2	4141	Q9P225
TIRIRDPNQGGKDIT	EIF4G3	141	O43432
PRKGRIAVGSDADVV	CRMP1	396	Q14194
DLEERAKVTSGVRPG	CNTNAP5	941	Q8WYK1
VSAQTPKGRRLSGEE	MPHOSPH8	381	Q99549
GEFVPGTRNRKVTIT	NOVA1	461	P51513
AGSLERNRVGVSSKP	MINK1	761	Q8N4C8
ERRPVKDGGGTNSIT	ABCC1	631	P33527
FVVTVKQERGEGPRA	HMG20B	26	Q9P0W2
LEEEKEGRTNVPGSR	NLRP3	536	Q96P20
RSPGSQGVRDFIEKR	NDUFA2	26	O43678
RTEEKKAPRRVNGEG	RSBN1L	46	Q6PCB5
GRVSKLRASVADPGQ	SYTL1	61	Q8IYJ3
RTPSEGEAGTQRQQK	VARS2	1016	Q5ST30
PGRKTEDTRQNEGVQ	SPATA31C2	981	B4DYI2
TKGNLGTIPTERAQR	PTAR1	161	Q7Z6K3
QGSRPGETEENVRRV	SPATA5L1	271	Q9BVQ7
RKRRITNEPTGGSGV	THSD7A	541	Q9UPZ6
PQLGTRKVARAEEAG	SERTAD4-AS1	41	Q5TG53
SAVVKQPVRGASGRT	PLAC8L1	46	A1L4L8
VGRREPEELGKTQFG	ODAD4	641	Q96NG3
QGITGARPKTDARAV	GPRASP2	91	Q96D09
RVKPDRTGVVTDGVK	ETFB	21	P38117
GSRVSPENLVDKSRG	NCOR1	2116	O75376
EQVEITVGRFRGQKP	EPPK1	2106	P58107
AEGRKPSGVSQEALR	SGSM2	96	O43147
PARGFREVVETQEGK	MRPS18A	31	Q9NVS2
TGRKGRVVSRPDGTV	SBNO2	751	Q9Y2G9
KAIPRRRVNSGDTEV	MYCBP2	3496	O75592
TAQERAKSRVRAVPG	RNF169	296	Q8NCN4
DGQTRPRVVKRGIDD	SEC23IP	416	Q9Y6Y8
TPGRKTEDTRQNEGV	SPATA31C1	986	P0DKV0
TGVVKIVVRQAPRDG	SRCAP	1306	Q6ZRS2
QRAGSEVISRGGPRK	TRIOBP	1921	Q9H2D6
EVISRGGPRKADGQR	TRIOBP	1926	Q9H2D6
RNSEGEVTGRLKVGP	SGCG	116	Q13326
VETGPRASRVVKLEG	SOX30	156	O94993
TTPEGNRIGTKGLER	SPAG17	1396	Q6Q759
ARGETEERARGAPKQ	C12orf42	146	Q96LP6
ITTKGSPRGELRGQV	CHRD	631	Q9H2X0
GRVRTTTIGEPENKS	CLCNKA	181	P51800
GRVRTTTIGEPENKS	CLCNKB	181	P51801
TSRDIEVQGFRIPKG	CYP2D7	396	A0A087X1C5
ASARPRGKGEVTQQT	SS18L1	6	O75177
LTVSEDGPGVRRQEE	SLC7A6OS	176	Q96CW6
DVRKRTGVAGSQPVS	USE1	136	Q9NZ43
EKTNRLGPEAAVGRA	ZNF488	51	Q96MN9
GQVTVEEKLTPRGER	ZNF3	156	P17036
VGAEGPVVLRSKDGR	SPTBN2	2361	O15020
EAQQLAGVRRGAKPE	TBC1D10C	376	Q8IV04
RLQREPGGTKNEVTA	ZNF75CP	126	Q92670
GRLESEGNVAPVRIS	ZNF408	136	Q9H9D4
AQLGKGERISAPERE	XAF1	136	Q6GPH4
GRPRAVRVGGKESEV	TNXB	1411	P22105
FGIQDGKRRSPVSVE	TNXB	1646	P22105
KDRDGRPQVVRVGGE	TNXB	2446	P22105
GRPQAVRVGGQESKV	TNXB	2561	P22105
KDRDGQPQVVRVRGE	TNXB	3201	P22105
ASTQTRRAPGGIKET	MLF1	126	P58340
VDPTRVAKSSGVEGR	ZBED10P	131	Q96FA7
GRQPGEVTREQQDAK	TRIM26	86	Q12899
GKGEVRPELGSRQDV	CAD	1656	P27708
TVLPGRSSEREGNAK	ZEB1	66	P37275
SSTGKRQEVQGRPGE	ZNF608	131	Q9ULD9
NVATPNRVDKRITDG	ZGRF1	1156	Q86YA3
SARTPAGKRVINQEE	ZNF830	6	Q96NB3
KQDRPVREGTRVASI	PHF8	891	Q9UPP1
EQPKFLGVREQRVTG	SLC4A4	866	Q9Y6R1
GEKQKPEQVSRTGGR	ZBTB32	146	Q9Y2Y4
RQGTPGEKNRALEAV	TCHHL1	596	Q5QJ38
GRPRSSVTVSVKGQE	ZSCAN29	101	Q8IWY8
TIKQESGRAGVRPSS	GTF3C1	831	Q12789
PDGEKVAQRIRGATD	VASH1	86	Q7L8A9
KRSAGVPVRGVELQA	TIGD7	91	Q6NT04
SIIRNVKGPVREGDV	RPS28	41	P62857
VRGQRPESGEEAVTL	ZNF202	106	O95125
PVQGRAEGRSSEGRK	nan	21	Q96M66
RKGPEGRRFQTEAAV	nan	16	Q8NAQ8
VPEGRTQGTLKAAAR	VWA5B1	1181	Q5TIE3
KDRGGGERPVNARVV	nan	76	Q8N402
QEVGESPGTRKRQRA	ZNF641	351	Q96N77
KSIAEGIGPEERRQT	GEMIN4	1036	P57678
GASQRSGITSPVEKR	KMT2D	2631	O14686
GEGFVNVTVKPARRV	KIAA0319	416	Q5VV43
RVRAVNANGVGKPSD	MYOM2	886	P54296